Literature DB >> 12823277

Participation of the interstitium in acute immune-complex nephritis: interstitial antigen accumulation, cellular infiltrate, and MHC class II expression.

G Parra1, S Hernández, P Moreno, B Rodríguez-Iturbe.   

Abstract

Bovine serum albumin (BSA) injected into the rabbits induces acute immune complex glomerulonephritis. Since albumin is filtered and reabsorbed in the tubules, we investigated whether tubulointerstitial cells participate in the pathogenesis of this experimental condition. For this purpose, we induced immune-complex nephritis in 45 rabbits with the injection of 125I-BSA and urinary BSA excretion, glomerular and tubulointerstitial BSA accumulation, lymphocyte infiltration, proliferative activity and MHC class II antigens were examined 2, 4-5 and 6-8 days after immunization. Proteinuria developed day 6-8. BSA was found in urine from day 2 (mean +/- SE; 1089 +/- 339 micro g/24 h) and peaked on day 4 after immunization (2249 +/- 1106). BSA content (cpm/g tissue) in tubulointerstitium (TI) and glomeruli were similar at day 2 (457 +/- 45 and 407 +/- 75, respectively), but afterward increased significantly in TI, reaching a peak level on day 5 (1026 +/- 406) while remained unchanged in glomeruli (388 +/- 95). At the same time, preceding the onset of proteinuria, maximal intensity of the lymphocyte infiltration, proliferative activity and MHC class II antigen expression in tubular cells, monocytes/macrophages and interstitial cells were observed. Our study shows that antigen is excreted in the urine and concentrated in TI in association with overexpression of MHC class II molecules and lymphocyte infiltration. These findings occur prior to the development of proteinuria and suggest that the tubulointerstitial cells play a critical role in the pathogenesis of this model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823277      PMCID: PMC1808748          DOI: 10.1046/j.1365-2249.2003.02188.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  The return of glomerular-filtered albumin to the rat renal vein.

Authors:  G A Eppel; T M Osicka; L M Pratt; P Jablonski; B O Howden; E F Glasgow; W D Comper
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

2.  Cyclosporin A reduces expression of adhesion molecules in the kidney of rats with chronic serum sickness.

Authors:  J Rincón; G Parra; Y Quiroz; L Benatuil; B Rodríguez-Iturbe
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

4.  Glomerular proliferative activity and T lymphocyte infiltration in acute serum sickness.

Authors:  G P Borges; P Moreno; B Rodríguez Iturbe
Journal:  Clin Immunol Immunopathol       Date:  1997-03

5.  Isolation and characterization of dendritic cells from mouse heart and kidney.

Authors:  J M Austyn; D F Hankins; C P Larsen; P J Morris; A S Rao; J A Roake
Journal:  J Immunol       Date:  1994-03-01       Impact factor: 5.422

6.  Acute serum sickness in normal and C6 deficient rabbits: role of membrane attack complex.

Authors:  G Parra; Y Takekoshi; J Striegel; R L Vernier; A F Michael
Journal:  Int J Exp Pathol       Date:  1992-06       Impact factor: 1.925

7.  Albumin permeability of the peritubular capillaries in rat renal cortex.

Authors:  D R Bell; G G Pinter; P D Wilson
Journal:  J Physiol       Date:  1978-06       Impact factor: 5.182

8.  Antigen-presenting capacity of rheumatoid synovial fibroblasts.

Authors:  A M Boots; A J Wimmers-Bertens; A W Rijnders
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

9.  T lymphocyte participation in acute serum sickness glomerulonephritis in rabbits.

Authors:  M G Lowe; S R Holdsworth; P G Tipping
Journal:  Immunol Cell Biol       Date:  1991-04       Impact factor: 5.126

10.  The role of monocytes in serum sickness nephritis.

Authors:  L G Hunsicker; T P Shearer; S B Plattner; D Weisenburger
Journal:  J Exp Med       Date:  1979-09-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.